Diagnostic Products Corporation Announces Sale of PathoDx Line to Remel.Business & Health/Medical Editors LOS ANGELES--(BUSINESS WIRE)--July 3, 2003 Diagnostic Products Corporation (NYSE NYSE See: New York Stock Exchange :DP) announced effective July 1, 2003, the sale of its PathoDx line of products to Remel Inc., a leading manufacturer and distributor of microbiology and laboratory diagnostic products, for approximately $4.9 million. The PathoDx line of products consists of manual latex agglutination agglutination, in biochemistry agglutination, in biochemistry: see immunity. agglutination, in linguistics agglutination, in linguistics: see inflection. and immunofluorescent immunofluorescent having the characteristic of immunofluorescence. immunofluorescent antibody test see fluorescence microscopy. immunofluorescent microscopy see fluorescence microscopy. microscopy diagnostic tests, and accounted for approximately $2.5 million of Diagnostic Products' revenue in 2002. In conjunction with the transaction, Diagnostic Products will continue to manufacture the PathoDx line for Remel for a period of up to two years. Founded in 1971, Diagnostic Products Corporation (DPC DPC Department of Premier and Cabinet (Victoria, Australia) DPC Dutch Power Cows DPC Deferred Procedure Calls (Microsoft Windows NT 4. ) is the global leader dedicated exclusively to immunodiagnostic immunodiagnostic pertaining to diagnosis by immune reactions. testing. The Company's product menu includes over 400 tests to measure microorganisms, hormones, drugs and other medically important substances present at infinitesimal in·fin·i·tes·i·mal adj. 1. Immeasurably or incalculably minute. 2. Mathematics Capable of having values approaching zero as a limit. n. 1. concentrations in body fluids and tissues. DPC also designs and manufactures automated laboratory instrumentation which provides fast, accurate results while reducing labor and reagent costs. DPC sells its products to hospitals, clinics and laboratories domestically and in over 100 countries. Additional Company information can be found on the Company's web site at www.dpcweb.com. Except for the historical information contained herein, this press release contains forward-looking statements that involve risks and uncertainties that could cause actual results to differ materially. These factors include the effects of governmental or other actions relating to relating to relate prep → concernant relating to relate prep → bezüglich +gen, mit Bezug auf +acc the Company's Chinese subsidiary; the rate of customer demand for the Company's products; the Company's ability to successfully market new and existing products; its dependence on certain suppliers; domestic and foreign government regulation; its ability to keep abreast of technological innovations and to translate them into new products; competition; political and economic instability in certain markets, including the movements of foreign currencies relative to the dollar; and other risks and uncertainties disclosed from time to time in the Company's SEC reports and filings. |
|
||||||||||||
Printer friendly
Cite/link
Email
Feedback
Reader Opinion